The influence of oral adsorbent AST-120 (Kremezin) on the anticonvulsive ef
fect and pharmacokinetics of zonisamide was investigated. Oral administrati
on of zonisamide (50 mg/kg) blocked the appearance of the tonic extension i
nduced by maximal electroshock seizure. This effect of zonisamide was inhib
ited by the oral coadministration of AST-120 (5 g/kg). In pharmacokinetics
study, the serum zonisamide concentration after coadministration of zonisam
ide and AST-120 was significantly lower than that of single administration
of zonisamide. However, the anticonvulsive effect of zonisamide was not aff
ected by the administration of AST-120 1.5 h after zonisamide administratio
n. In this condition, the serum zonisamide concentration was not changed. I
n the in vitro study, AST-120 completely adsorbed zonisamide. These finding
s suggest that when AST-120 is administered concurrently with zonisamide, a
significant inhibition of the anticonvulsive effect of zonisamide occurs,
and the decrease in serum zonisamide concentration by the adsorption effect
of AST-120 is related to this phenomenon. (C) 2001 Elsevier Science Inc. A
ll rights reserved.